cytarabine has been researched along with Teratoma in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (71.43) | 18.7374 |
| 1990's | 5 (23.81) | 18.2507 |
| 2000's | 1 (4.76) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Canivet, M; Dianoux, L; Hojman-Montes de Oca, F; Lasneret, J; Périès, J; Ravicovitch-Ravier, R | 1 |
| Bagshawe, KD; Begent, RH; Newlands, ES; Parker, D; Rustin, GJ | 1 |
| Ghavimi, F; Miller, DR; Rosen, G; Steinherz, PG; Wang, Y; Wollner, N | 1 |
| Aizawa, S; Loeb, LA; Martin, GM | 1 |
| Breithaupt, H; Eckhardt, T; Löffler, H; Pralle, H; Schick, J; von Hattingberg, M | 1 |
| Pandha, HS; Wasan, HS; Waxman, J | 1 |
| Anthoney, A; de Bono, JS; Graham, J; Kaye, SB; Kirk, D; Paul, J; Simpson, A; Underwood, M | 1 |
| Russell, DH; Russell, SD | 1 |
| Douglas, ID; Gordon, MY | 1 |
| Green, JA; Husband, DJ | 1 |
| Deeb, SS; Fukuchi, K; Kamino, K; Martin, GM; Ogburn, CE; Piussan, H; Sekiguchi, RT; Snow, AD; Wight, TN | 1 |
| Baltimore, D; Chun, JJ; Jaenisch, R; Oettinger, MA; Schatz, DG | 1 |
| Adachi, S; Hirooka, C; Ichijo, M; Kiyozuka, Y; Noda, T; Oku, M; Yamamoto, T | 1 |
| Bagshawe, KD; Begent, RH; Crawford, SM; Holden, L; Newlands, ES; Rustin, GJ | 1 |
| Clarke, J; Cullen, MH; Harper, PG; Kirkbride, P; Woodroffe, CM | 1 |
| Kosaka, M; Matsumoto, K; Nishimune, Y; Nishina, Y; Sakuda, M; Sumi, T; Takeda, M | 1 |
| Wilkinson, PM | 1 |
| Berek, JS; Knox, RM; Schink, JC | 1 |
| Andrews, PW; Dignazio, M; Gönczöl, E; Oosterhuis, JW; Plotkin, SA | 1 |
| Aizawa, S; Ikawa, Y; Suda, Y | 1 |
| Aizawa, S; Loeb, LA; Martin, GM; Ohashi, M | 1 |
2 trial(s) available for cytarabine and Teratoma
| Article | Year |
|---|---|
POMB/ACE chemotherapy in non-seminomatous germ cell tumours: outcome and importance of dose intensity.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Cytarabine; Dactinomycin; Dose-Response Relationship, Drug; Etoposide; Humans; Male; Mediastinal Neoplasms; Mesonephroma; Methotrexate; Middle Aged; Prognosis; Retroperitoneal Neoplasms; Teratoma; Testicular Neoplasms; Time Factors; Vincristine | 1992 |
Treatment of patients with poor prognosis anaplastic germ cell tumours (AGCT) of the testis and other sites.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Dactinomycin; Drug Administration Schedule; Dysgerminoma; Etoposide; Humans; Male; Methotrexate; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Teratoma; Testicular Neoplasms; Vincristine | 1987 |
19 other study(ies) available for cytarabine and Teratoma
| Article | Year |
|---|---|
Regulation of intracisternal A particles in mouse teratocarcinoma cells: involvement of DNA methylation in transcriptional control.
Topics: Animals; Azacitidine; Cell Differentiation; Cytarabine; DNA, Viral; Gene Expression Regulation; Inclusion Bodies, Viral; Methylation; Mice; RNA, Viral; Teratoma | 1984 |
Further advances in the management of malignant teratomas of the testis and other sites.
Topics: alpha-Fetoproteins; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chorionic Gonadotropin; Cyclophosphamide; Cytarabine; Dactinomycin; Drug Therapy, Combination; Etoposide; Humans; Lung Neoplasms; Male; Mediastinal Neoplasms; Methotrexate; Neoplasm Staging; Prognosis; Retroperitoneal Neoplasms; Teratoma; Testicular Neoplasms; Vincristine | 1983 |
Higher leukocyte nadirs with lithium carbonate after chemotherapy.
Topics: Adolescent; Adult; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Female; Humans; Hydroxyurea; Leukocyte Count; Lithium; Male; Nasopharyngeal Neoplasms; Neoplasms; Neuroblastoma; Papaverine; Rhabdomyosarcoma; Sarcoma, Ewing; Teratoma; Trifluridine; Vincristine; Wilms Tumor | 1980 |
Mouse teratocarcinoma cells resistant to aphidicolin and arabinofuranosyl cytosine: isolation and initial characterization.
Topics: Animals; Aphidicolin; Cell Line; Cell Separation; Cytarabine; Diterpenes; Dose-Response Relationship, Drug; Drug Resistance; Methylnitronitrosoguanidine; Mice; Teratoma | 1983 |
Clinical results and pharmacokinetics of high-dose cytosine arabinoside (HD ARA-C).
Topics: Adult; Arabinofuranosyluracil; Cytarabine; Drug Administration Schedule; Female; Gastrointestinal Diseases; Half-Life; Humans; Kinetics; Leukemia; Male; Metabolic Clearance Rate; Middle Aged; Teratoma; Time Factors | 1982 |
Failure of normalization of alphafetoprotein levels following the successful treatment of teratoma: a diagnostic trap for the unwary.
Topics: Adult; Alcohol Drinking; alpha-Fetoproteins; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dactinomycin; Etoposide; Humans; Male; Methotrexate; Orchiectomy; Teratoma; Thoracotomy; Vincristine | 1995 |
Improving the outcome of salvage treatment for non-seminomatous germ cell tumours (NSGCT).
Topics: Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chorionic Gonadotropin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dactinomycin; Disease-Free Survival; Etoposide; Humans; Ifosfamide; Male; Methotrexate; Neoplasm Recurrence, Local; Retrospective Studies; Salvage Therapy; Teratoma; Testicular Neoplasms; Treatment Outcome; Vinblastine; Vincristine | 2000 |
Relative usefulness of measuring polyamines in serum, plasma, and urine as biochemical markers of cancer.
Topics: Bleomycin; Cadaverine; Chromatography, Ion Exchange; Cytarabine; Diamines; Humans; Multiple Myeloma; Plasma; Prednisone; Putrescine; Spermidine; Spermine; Teratoma; Vinblastine; Vincristine | 1975 |
Changes in proliferation rate of human bone marrow colony-forming cells measured by a cytosine arabinoside-diffusion chamber method.
Topics: Animals; Bone Marrow; Bone Marrow Cells; Bronchial Neoplasms; Cell Survival; Cells, Cultured; Clone Cells; Cyclophosphamide; Cytarabine; Dose-Response Relationship, Drug; Humans; Male; Mice; Mice, Inbred C57BL; Mitosis; Teratoma; Time Factors | 1976 |
Increased expression of beta-amyloid protein precursor and microtubule-associated protein tau during the differentiation of murine embryonal carcinoma cells.
Topics: Amyloid beta-Protein Precursor; Animals; Cell Differentiation; Cytarabine; Immunohistochemistry; Mice; Microtubule-Associated Proteins; Neurons; RNA, Messenger; tau Proteins; Teratoma; Tumor Cells, Cultured | 1992 |
The recombination activating gene-1 (RAG-1) transcript is present in the murine central nervous system.
Topics: Aging; Animals; Base Sequence; Brain; Cell Division; Cell Line; Chromosome Mapping; Cytarabine; Genes; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Neurons; Nucleic Acid Hybridization; Oligonucleotide Probes; Organ Specificity; Polymerase Chain Reaction; Recombination, Genetic; RNA Probes; Teratoma; Transcription, Genetic; Tretinoin | 1991 |
[Intraperitoneal (i.p.) chemotherapy in the management of ovarian cancer--pharmacokinetics and methods of sequential i.p. chemotherapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arabinofuranosyluracil; Carcinoma, Squamous Cell; Child; Cisplatin; Cystadenocarcinoma; Cytarabine; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Infusion Pumps; Infusions, Parenteral; Middle Aged; Ovarian Neoplasms; Teratoma | 1990 |
Chemotherapy for poor risk germ cell tumours. An independent evaluation of the POMB/ACE regime.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Cytarabine; Dactinomycin; Dysgerminoma; Etoposide; Humans; Male; Methotrexate; Neoplasms, Germ Cell and Embryonal; Teratoma; Testicular Neoplasms; Vincristine | 1988 |
Inhibition of DNA synthesis causes stem cell differentiation: induction of teratocarcinoma F9 cell differentiation with nucleoside analogues of DNA-synthesis inhibitors and their inducing abilities counterbalanced specifically by normal nucleosides.
Topics: Animals; Bromodeoxyuridine; Cell Differentiation; Cell Line; Cytarabine; DNA Replication; DNA, Neoplasm; Floxuridine; Hematopoietic Stem Cells; Idoxuridine; Kinetics; Mice; Mutation; Nucleosides; Plasminogen Activators; Teratoma; Thymidine Kinase | 1989 |
Chemotherapy for non-seminomatous germ-cell tumours.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Cisplatin; Cyclophosphamide; Cytarabine; Dactinomycin; Etoposide; Humans; Male; Methotrexate; Teratoma; Testicular Neoplasms; Vinblastine; Vincristine | 1985 |
Synergistic effect of combined intraperitoneal cisplatin and cytosine arabinoside in a murine ovarian cancer model.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Female; Mice; Mice, Inbred C3H; Ovarian Neoplasms; Teratoma | 1989 |
Differentiation of TERA-2 human embryonal carcinoma cells into neurons and HCMV permissive cells. Induction by agents other than retinoic acid.
Topics: Acetamides; Bromodeoxyuridine; Butyrates; Butyric Acid; Cell Differentiation; Cell Line; Cisplatin; Clone Cells; Cyclic AMP; Cytarabine; Dimethyl Sulfoxide; Humans; Idoxuridine; Kinetics; Neurons; Teratoma; Tetradecanoylphorbol Acetate; Tretinoin | 1986 |
Chimeric potency of a mutator strain of mouse teratocarcinoma cells.
Topics: Animals; Blastocyst; Cell Line; Chimera; Cytarabine; Embryo Transfer; Female; Mice; Mutation; Phenotype; Pregnancy; Teratoma; Tissue Distribution | 1986 |
Multipotent mutator strain of mouse teratocarcinoma cells.
Topics: Animals; Cell Line; Chimera; Cytarabine; Deoxycytosine Nucleotides; Drug Resistance; Embryonal Carcinoma Stem Cells; Mice; Mutation; Neoplasm Transplantation; Neoplastic Stem Cells; Ouabain; Phenotype; Teratoma; Thioguanine; Transplantation, Isogeneic | 1985 |